Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 111 (7), 1177-87

Are Take-Home Naloxone Programmes Effective? Systematic Review Utilizing Application of the Bradford Hill Criteria


Are Take-Home Naloxone Programmes Effective? Systematic Review Utilizing Application of the Bradford Hill Criteria

Rebecca McDonald et al. Addiction.


Background and aims: Fatal outcome of opioid overdose, once detected, is preventable through timely administration of the antidote naloxone. Take-home naloxone provision directly to opioid users for emergency use has been implemented recently in more than 15 countries worldwide, albeit mainly as pilot schemes and without formal evaluation. This systematic review assesses the effectiveness of take-home naloxone, with two specific aims: (1) to study the impact of take-home naloxone distribution on overdose-related mortality; and (2) to assess the safety of take-home naloxone in terms of adverse events.

Methods: PubMed, MEDLINE and PsychINFO were searched for English-language peer-reviewed publications (randomized or observational trials) using the Boolean search query: (opioid OR opiate) AND overdose AND prevention. Evidence was evaluated using the nine Bradford Hill criteria for causation, devised to assess a potential causal relationship between public health interventions and clinical outcomes when only observational data are available.

Results: A total of 1397 records (1164 after removal of duplicates) were retrieved, with 22 observational studies meeting eligibility criteria. Due to variability in size and quality of the included studies, meta-analysis was dismissed in favour of narrative synthesis. From eligible studies, we found take-home naloxone met all nine Bradford Hill criteria. The additional five World Health Organization criteria were all either met partially (two) or fully (three). Even with take-home naloxone administration, fatal outcome was reported in one in 123 overdose cases (0.8%; 95% confidence interval = 0.4, 1.2).

Conclusions: Take-home naloxone programmes are found to reduce overdose mortality among programme participants and in the community and have a low rate of adverse events.

Keywords: Bradford Hill; death; heroin; naloxone; opiate; opioid; overdose; prevention.


Figure 1
Figure 1
Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) flow diagram of study selection process

Comment in

Similar articles

See all similar articles

Cited by 41 articles

See all "Cited by" articles


    1. United Nations Office on Drugs and Crime/World Health Organization (UNODC/WHO) . Opioid Overdose: Preventing and Reducing Opioid Overdose Mortality. Vienna: United Nations; 2013. Available at: (accessed 30 May 2014). (Archieved at on 24 February 2016.)
    1. Degenhardt L., Bucello C., Mathers B., Briegleb C., Ali H., Hickman M., et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta‐analysis of cohort studies. Addiction 2011; 106: 32–51. - PubMed
    1. World Health Organization (WHO) . Community management of opioid overdose 2014. Available at: (accessed 11 November 2014). (Archieved at on 24 February 2016.)
    1. Strang J., Darke S., Hall W., Farrell M., Ali R. Heroin overdose: the case for take‐home naloxone. BMJ 1996; 312: 1435. - PMC - PubMed
    1. Williams A. V., Marsden J., Strang J. Training family members to manage heroin overdose and administer naloxone: randomized trial of effects on knowledge and attitudes. Addiction 2014; 109: 250–9. - PubMed

MeSH terms